INTECH Investment Management’s Neuropace NPCE Stock Holding History
Bought
Maintained
Sold
Other funds holding NPCE
PCH
SCM
O
FLAM
AC
KLP
DCM
INTECH Investment Management's NPCE Position: Q3 2025 in Review
INTECH Investment Management sold out of Neuropace (NPCE) in Q3 2025, closing a stake of 14,572 shares — an estimated $162K sold.
INTECH Investment Management first reported a position in NPCE in Q2 2025 and held it in 1 quarter. The position peaked at $162K in Q2 2025. 80 funds tracked by Wall St. Rank hold NPCE as of Q3 2025.
- INTECH Investment Management reported no remaining Neuropace position as of Q3 2025 after selling out during the quarter.
- INTECH Investment Management sold 14,572 Neuropace shares in Q3 2025, an estimated $162K.
- INTECH Investment Management first reported a position in Neuropace in Q2 2025 and held it in 1 quarter.
- INTECH Investment Management's Neuropace position peaked at $162K in Q2 2025.
- 80 funds tracked by Wall St. Rank held Neuropace as of Q3 2025.
Based on INTECH Investment Management's 13F filing for Q3 2025, filed 12 Nov 2025.